CRBU Caribou Biosciences
- 3.775
- +0.065+1.75%
Caribou Biosciences News
Analysts Offer Insights on Healthcare Companies: 3SBio (OtherTRSBF), UnitedHealth (UNH) and Caribou Biosciences (CRBU)
Analysts Are Bullish on Top Healthcare Stocks: Paragon 28 (FNA), Caribou Biosciences (CRBU)
HC Wainwright Adjusts Caribou Biosciences Price Target to $24 From $23, Maintains Buy Rating
Analysts' Opinions Are Mixed on These Healthcare Stocks: Fusion Pharmaceuticals (FUSN), Caribou Biosciences (CRBU) and Neurogene (NGNE)
Caribou Biosciences Analyst Ratings
Caribou Biosciences (CRBU) Gets a Buy From Truist Financial
Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), Medtronic (MDT) and Caribou Biosciences (CRBU)
Optimistic Outlook for Caribou Biosciences With a Buy Rating and $20 Price Target
Caribou Biosciences Analyst Ratings
RBC Capital Reiterates Outperform on Caribou Biosciences, Maintains $19 Price Target
RBC Capital Remains a Buy on Caribou Biosciences (CRBU)
RBC Capital Keeps Their Buy Rating on Caribou Biosciences (CRBU)
Strategic FDA Alignment and Promising Trial Results Underpin Buy Rating for Caribou Biosciences
Analysts Are Bullish on These Healthcare Stocks: Avidity Biosciences (RNA), Caribou Biosciences (CRBU)
Caribou Biosciences: Strong Financial Performance and Promising Clinical Catalysts Reinforce Buy Rating
Analysts' Top Healthcare Picks: Xenon (XENE), Caribou Biosciences (CRBU)
Caribou Biosciences (CRBU) Gets a Buy From RBC Capital
Caribou Biosciences Analyst Ratings
FDA Clearance and Innovative Therapy Drive Buy Rating for Caribou Biosciences
Analysts Offer Insights on Healthcare Companies: Galecto (GLTO), Encompass Health (EHC) and Caribou Biosciences (CRBU)
Analysis
Price Target
No Data
